Virginie Lhiaubet-Vallet Selected Research

Photoallergic Dermatitis (Photoallergy)

9/2022	Pterin-lysine photoadduct: a potential candidate for photoallergy.
1/2016	Photosensitivity to Triflusal: Formation of a Photoadduct with Ubiquitin Demonstrated by Photophysical and Proteomic Techniques.
7/2009	Photonucleophilic addition of the epsilon-amino group of lysine to a triflusal metabolite as a mechanistic key to photoallergy mediated by the parent drug.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Virginie Lhiaubet-Vallet Research Topics

Disease

14	Photosensitivity Disorders (Photodermatitis) 10/2021 - 02/2004
3	Photoallergic Dermatitis (Photoallergy) 09/2022 - 07/2009
3	Phototoxic Dermatitis (Phototoxicity) 05/2018 - 01/2009
2	Skin Neoplasms (Skin Cancer) 11/2020 - 09/2012
2	Neoplasms (Cancer) 05/2018 - 11/2014
2	Psychotic Disorders (Schizoaffective Disorder) 11/2013 - 07/2009
1	Dermatitis 03/2018
1	Thromboembolism 01/2016
1	Schizophrenia (Dementia Praecox) 11/2013

Drug/Important Bio-Agent (IBA)

8	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 02/2004
3	OligonucleotidesIBA 10/2021 - 02/2004
3	Pharmaceutical PreparationsIBA 05/2018 - 07/2009
2	Lysine (L-Lysine)FDA Link 09/2022 - 07/2009
2	PterinsIBA 09/2022 - 10/2021
2	ThymineIBA 10/2021 - 10/2018
2	Imatinib Mesylate (Gleevec)FDA Link 05/2018 - 11/2014
2	Sunscreening Agents (Sunscreens)IBA 03/2018 - 04/2010
2	benzophenoneIBA 04/2016 - 09/2012
2	4-trifluoromethylsalicylic acid (HTB)IBA 01/2016 - 07/2009
2	triflusalIBA 01/2016 - 07/2009
2	NucleosidesIBA 09/2012 - 07/2007
2	Photosensitizing Agents (Photosensitizers)IBA 09/2012 - 01/2009
2	Singlet OxygenIBA 04/2010 - 01/2009
1	GuanineIBA 10/2021
1	NucleotidesIBA 10/2021
1	Nucleic AcidsIBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	Monophenol Monooxygenase (Tyrosinase)IBA 05/2018
1	UracilIBA 04/2016
1	AcetoneIBA 04/2016
1	PyrimidinonesIBA 01/2016
1	5-hydroxy-5,6-dihydrothymineIBA 01/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2016
1	ProdrugsIBA 01/2016
1	Sepharose (Agarose)IBA 11/2014
1	Tyrosine Kinase InhibitorsIBA 11/2014
1	PorphyrinsIBA 11/2014
1	5-methyl-2-pyrimidone deoxyribonucleosideIBA 06/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2011
1	Rosuvastatin Calcium (Crestor)FDA Link 10/2011
1	Antipsychotic Agents (Antipsychotics)IBA 07/2009
1	Human Serum Albumin FDA LinkGeneric 07/2009
1	Chlorprothixene (Taractan)FDA Link 07/2009
1	Atorvastatin (Lipitor)FDA Link 01/2009
1	phenanthreneIBA 01/2009
1	LipidsIBA 01/2009
1	Tyrosine (L-Tyrosine)FDA Link 07/2007
1	ThymidineIBA 07/2007
1	Tryptophan (L-Tryptophan)FDA Link 07/2007
1	Amino Acids FDA Link 07/2007
1	mannose-6-phosphate rich phosphomannanIBA 03/2007
1	EstersIBA 02/2004
1	phage T4 endonuclease VIBA 02/2004
1	Indoprofen (Dexindoprofen)IBA 02/2004
1	Pyrimidine DimersIBA 02/2004

Therapy/Procedure

1	Lasers (Laser) 11/2014